Rudi Pauwels
About
Rudi Pauwels is a scholar working on Infectious Diseases, Virology and Molecular Biology.
According to data from OpenAlex, Rudi Pauwels has authored 145 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Infectious Diseases, 98 papers in Virology and 38 papers in Molecular Biology. Recurrent topics in Rudi Pauwels's work include HIV/AIDS drug development and treatment (101 papers), HIV Research and Treatment (98 papers) and HIV/AIDS Research and Interventions (28 papers). Rudi Pauwels is often cited by papers focused on HIV/AIDS drug development and treatment (101 papers), HIV Research and Treatment (98 papers) and HIV/AIDS Research and Interventions (28 papers). Rudi Pauwels collaborates with scholars based in Belgium, United States and Netherlands. Rudi Pauwels's co-authors include Erik De Clercq, Masanori Baba, Jan Balzarini, Dominique Schols, Jan Desmyter, Piet Herdewijn, Robert Snoeck, Koen Andries, Marie‐Pierre de Béthune and Hilde Azijn and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Rudi Pauwels
144 papers receiving 14.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Rudi Pauwels Belgium | 63 | 9.2k | 8.1k | 4.4k | 3.4k | 2.8k | 145 | 14.9k | ||
| Masanori Baba Japan | 62 | 6.9k 0.8× | 5.9k 0.7× | 5.0k 1.1× | 3.3k 1.0× | 3.6k 1.3× | 372 | 16.0k | ||
| Daria J. Hazuda United States | 59 | 7.0k 0.8× | 7.4k 0.9× | 5.5k 1.3× | 2.2k 0.6× | 1.2k 0.4× | 189 | 13.7k | ||
| Jan Desmyter Belgium | 52 | 4.9k 0.5× | 4.1k 0.5× | 2.0k 0.5× | 2.9k 0.9× | 1.2k 0.4× | 207 | 10.2k | ||
| Carlo Federico Perno Italy | 56 | 8.0k 0.9× | 6.9k 0.9× | 2.5k 0.6× | 3.5k 1.0× | 1.2k 0.4× | 558 | 13.4k | ||
| Samuel Broder United States | 57 | 5.8k 0.6× | 5.1k 0.6× | 3.0k 0.7× | 2.8k 0.8× | 1.1k 0.4× | 121 | 12.3k | ||
| Hiroaki Mitsuya United States | 74 | 14.1k 1.5× | 12.2k 1.5× | 7.8k 1.8× | 4.8k 1.4× | 3.5k 1.2× | 522 | 25.5k | ||
| Antonı́n Holý Czechia | 49 | 5.3k 0.6× | 1.9k 0.2× | 5.9k 1.4× | 4.6k 1.4× | 3.6k 1.3× | 587 | 12.5k | ||
| Mark A. Wainberg Canada | 71 | 14.7k 1.6× | 15.5k 1.9× | 6.0k 1.4× | 4.0k 1.2× | 502 0.2× | 588 | 21.3k | ||
| Piet Herdewijn Belgium | 64 | 6.0k 0.7× | 2.9k 0.4× | 12.5k 2.9× | 2.9k 0.8× | 5.2k 1.9× | 787 | 19.5k | ||
| William A. Schleif United States | 36 | 6.5k 0.7× | 6.7k 0.8× | 2.5k 0.6× | 1.3k 0.4× | 1.6k 0.6× | 92 | 9.4k |
Countries citing papers authored by Rudi Pauwels
Since
Specialization
Citations
This map shows the geographic impact of Rudi Pauwels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudi Pauwels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudi Pauwels more than expected).
Fields of papers citing papers by Rudi Pauwels
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Rudi Pauwels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudi Pauwels. The network helps show where Rudi Pauwels may publish in the future.
Co-authorship network of co-authors of Rudi Pauwels
This figure shows the co-authorship network connecting the top 25 collaborators of Rudi Pauwels. A scholar is included among the top collaborators of Rudi Pauwels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rudi Pauwels. Rudi Pauwels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Swart, Pieter, Martin C. Harmsen, Mirjam Kuipers, et al.. (1999). Charge modification of plasma and milk proteins results in antiviral active compounds. Journal of Peptide Science. 5(12). 563–563.
2.
Miller, Veronica, Andrew Phillips, Schlomo Staszewski, et al.. (1998). Dual Resistance to Zidovudine and Lamivudine in Patients Treated with Zidovudine‐Lamivudine Combination Therapy: Association with Therapy Failure. The Journal of Infectious Diseases. 177(6). 1521–1532.
3.
Das, Kalyan, Jianping Ding, Y. Hsiou, et al.. (1996). Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant. Journal of Molecular Biology. 264(5). 1085–1100.
4.
Poujade, Christèle, Michel Evers, Jean‐Christophe Carry, et al.. (1996). Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry. Journal of Medicinal Chemistry. 39(5). 1069–1083.
5.
Vandamme, Anne–Mieke, Zeger Debyser, Rudi Pauwels, et al.. (1994). Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913. AIDS Research and Human Retroviruses. 10(1). 39–46.
6.
Bârzu, Tereza, Maurice Petitou, J C Lormeau, et al.. (1993). Preparation and anti-HIV activity of O-acylated heparin and dermatan sulfate derivatives with low anticoagulant effect. Journal of Medicinal Chemistry. 36(23). 3546–3555.
7.
Vreese, K De, Zeger Debyser, Anne–Mieke Vandamme, et al.. (1992). Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis. Virology. 188(2). 900–904.
8.
Debyser, Zeger, Rudi Pauwels, Masanori Baba, Jan Desmyter, & Erik De Clercq. (1992). Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.. Molecular Pharmacology. 41(5). 963–968.
9.
Kukla, Michael J., et al.. (1991). Synthesis and anti-HIV-1 activity of 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one (TIBO) derivatives. Journal of Medicinal Chemistry. 34(2). 746–751.
10.
Witvrouw, Myriam, Dominique Schols, Graciela Andreï, et al.. (1991). Antiviral Activity of low-MW Dextran Sulphate (Derived from dextran MW 1000) Compared to Dextran Sulphate Samples of Higher MW. Antiviral chemistry & chemotherapy. 2(3). 171–179.
11.
Jansen, Robert W., Grietje Molema, Rudi Pauwels, et al.. (1991). Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.. Molecular Pharmacology. 39(6). 818–823.
12.
Debyser, Zeger, et al.. (1991). Allosteric properties of heterodimeric HIV-1 reverse transcriptase. 128.
13.
Pauwels, Rudi, Koen Andries, Jan Desmyter, et al.. (1990). Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature. 343(6257). 470–474.
14.
Baba, Masaya, Erik De Clercq, Dominique Schols, et al.. (1990). Novel Sulfated Polysaccharides: Dissociation of Anti-Human Immunodeficiency Virus Activity from Antithrombin Activity. The Journal of Infectious Diseases. 161(2). 208–213.
15.
Balzarini, Jan, Arthur Van Aerschot, Rudi Pauwels, et al.. (1989). 5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.. Molecular Pharmacology. 35(5). 571–577.
16.
Aerschot, Arthur Van, Piet Herdewijn, Jan Balzarini, Rudi Pauwels, & Erik De Clercq. (1989). 3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analogs. Journal of Medicinal Chemistry. 32(8). 1743–1749.
17.
Balzarini, Jan, Mitsuo Baba, Rudi Pauwels, Piet Herdewijn, & Erik De Clercq. (1988). 3'-fluoro-azido-substituted and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside derivatives are potent anti-retrovirus agents. Antiviral Research. 9. 120–120.
18.
Pauwels, Rudi, Jan Balzarini, Masanori Baba, et al.. (1988). Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods. 20(4). 309–321.
19.
Balzarini, Jan, Piet Herdewijn, Rudi Pauwels, Samuel Broder, & Erik De Clercq. (1988). ga,β- and β,γ-methylene 5'-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine-5'-triphosphate. Biochemical Pharmacology. 37(12). 2395–2403.
20.
Pauwels, Rudi, H. Bazin, Bernadette Platteau, & M. Van Der Straeten. (1978). 120. The influence of genetic factors and antigen dose on IgE production in rats. Journal of Allergy and Clinical Immunology. 61(3). 164–165.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Masanori Baba Breakdown of academic impact, for papers by Daria J. Hazuda Breakdown of academic impact, for papers by Jan Desmyter Breakdown of academic impact, for papers by Carlo Federico Perno Breakdown of academic impact, for papers by Samuel Broder Breakdown of academic impact, for papers by Hiroaki Mitsuya Breakdown of academic impact, for papers by Antonı́n Holý Breakdown of academic impact, for papers by Mark A. Wainberg Breakdown of academic impact, for papers by Piet Herdewijn Breakdown of academic impact, for papers by William A. Schleif